Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals, Inc.

Cardiovascular drug development

Aegerion developed and commercialized innovative drugs for patients with rare diseases.

Aegerion went public on NASDAQ in 2010.